Archive:Venalex: Difference between revisions
m 29 revisions imported |
remove deletion notice Tag: Manual revert |
||
| Line 1: | Line 1: | ||
{{More citations needed|date=September 2024}} | {{More citations needed|date=September 2024}} | ||
{{Notability|product|date=September 2026}} | {{Notability|product|date=September 2026}} | ||
Revision as of 21:45, 29 September 2026
Template:More citations needed
 |
This article may not meet the general notability guideline. Please help to establish notability by adding reliable, secondary sources about the topic. If notability cannot be established, the article is likely to be merged or deleted. (September 2026) |
Venalex is a dietary supplement micronized purified flavenoid fraction (MPFF). It is a vegan, gluten-free nutritional supplement.[1]
Medical uses
Venalex is used to treat chronic functional or structural venous insufficiency of the lower limbs.[2]
No results of clinical trials have been published. Venalex is not currently approved by the FDA.[3]
Components
Active ingredients
Venalex is made with a 9-1 ratio of diosmin and hesperidin.[2]
Other ingredients
Hydroxypropol methylcellulose, magnesium stearate.
References
- ↑ "venalex" (in en-US). https://purelife-nutritions.com/venalex-diosmin-450-mg-hesperidin-50-mg-mpff-micronized-purified-flavonoid-fraction/.
- ↑ 2.0 2.1 "What is Venalex?". http://ethifarm.pl/en/products/venalex/what-is-venalex.
- ↑ Research, Center for Drug Evaluation and (2024-09-06). "Drug Approvals and Databases" (in en). https://www.fda.gov/drugs/development-approval-process-drugs/drug-approvals-and-databases.